Literature DB >> 17767206

Avascular necrosis of the femoral head in sickle cell disease in Nigeria: a retrospective study.

A L Akinyoola1, I A Adediran, C M Asaleye.   

Abstract

BACKGROUND: Avascular necrosis (AVN) especially of the femoral head, has long been recognised as a manifestation of sickle cell disease (SCD). Despite this knowledge the actual prevalence of this complication among sickle cell patients in Nigeria is not known.
OBJECTIVE: To determine the prevalence and patterns of presentation of avascular necrosis of the femoral head in sickle cell disease. PATIENTS AND METHODS: A retrospective study carried out at the Orthopaedic and Haematology clinics of Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria. Four hundred and sixteen patients with sickle cell disease seen over a 15-year period.
RESULTS: Of the 416 patients with sickle cell disease 340 (81.7%) had haemoglobin SS genotype while 76(18.3%) had SC genotype. Sixty-six (15.9%) patients 35 males (53%) and 31 females (47%) had clinical and radiologic features of avascular necrosis (AVN) of the femoral head. Fifty-three of them (80.3%) had Hb SS while 13 had Hb SC. The peak age incidence in both Hb SS and Hb SC was 21-30 years. Forty patients (60.6%) presented with stage IV disease (Ficat and Arlet Staging) while 21.2% had stage III and 18.2% had stage II. No patient was diagnosed in stage 1 or 0.
CONCLUSION: The prevalence of AVN of femoral head in Hb SC and HbSS is similar i.e. the difference is not statistically significant (P=0.48). Most of our patients present late with advanced diseases. Considering the paucity of facilities available for total hip replacement in Nigeria and the young age group affected we recommend regular screening of patients with sickle cell disorder for AVN and regular community educational programmes for early diagnosis.

Entities:  

Mesh:

Year:  2007        PMID: 17767206

Source DB:  PubMed          Journal:  Niger Postgrad Med J


  13 in total

1.  Avascular Necrosis of the Hip in Sickle Cell Disease in Oman: Is it serious enough to warrant bone marrow transplantation?

Authors:  Yasser Wali; Sultan Almaskari
Journal:  Sultan Qaboos Univ Med J       Date:  2011-02-12

2.  Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California.

Authors:  Oyebimpe Adesina; Ann Brunson; Theresa H M Keegan; Ted Wun
Journal:  Blood Adv       Date:  2017-07-11

3.  Symptomatic Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization by Patients with SCD.

Authors:  Tiffany Yu; Timothy Campbell; Isabella Ciuffetelli; Carlton Haywood; Christopher Patrick Carroll; Linda Resar; John J Strouse; Sophie Lanzkron
Journal:  South Med J       Date:  2016-09       Impact factor: 0.954

4.  Chronic osteo-articular changes in patients with sickle cell disease.

Authors:  Taciana Fernandes Araújo Ferreira; Ana Paula Teixeira Dos Santos; Alexandra Silva Leal; Gilberto de Araújo Pereira; Sheila Soares Silva; Helio Moraes-Souza
Journal:  Adv Rheumatol       Date:  2021-02-19

5.  Hemoglobin to Hematocrit Ratio: The Strongest Predictor of Femoral Head Osteonecrosis in Children With Sickle Cell Disease.

Authors:  Douglas Worrall; Kim Smith-Whitley; Lawrence Wells
Journal:  J Pediatr Orthop       Date:  2016-03       Impact factor: 2.324

6.  Patterns of opioid use in sickle cell disease.

Authors:  Jin Han; Santosh L Saraf; Xu Zhang; Michel Gowhari; Robert E Molokie; Joharah Hassan; Chaher Alhandalous; Shivi Jain; Jewel Younge; Taimur Abbasi; Roberto F Machado; Victor R Gordeuk
Journal:  Am J Hematol       Date:  2016-08-08       Impact factor: 10.047

7.  Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease.

Authors:  A L Akinyoola; I A Adediran; C M Asaleye; A R Bolarinwa
Journal:  Int Orthop       Date:  2008-07-17       Impact factor: 3.075

8.  Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging.

Authors:  S Sharma; W-H Leung; P Deqing; J Yang; R Rochester; L Britton; M D Neel; K K Ness; S C Kaste
Journal:  Bone Marrow Transplant       Date:  2011-12-12       Impact factor: 5.483

9.  Prevalence of osteonecrosis and associated risk factors in children before allogeneic BMT.

Authors:  S Sharma; S Yang; R Rochester; L Britton; W H Leung; J Yang; M D Neel; K K Ness; S C Kaste
Journal:  Bone Marrow Transplant       Date:  2010-09-06       Impact factor: 5.483

Review 10.  Epidemiology of sickle cell disease in Saudi Arabia.

Authors:  Wasil Jastaniah
Journal:  Ann Saudi Med       Date:  2011 May-Jun       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.